PALISADE BIO, INC. (PALI) › Shareholders' EquityPALISADE BIO, INC. (PALI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: -$2.56M2009: -$5.02M2010: $7.85M2011: $1.66M2012: $6.97M2013: $8.42M2014: $17.72M2015: $4.97M2016: $11.33M2017: $8.52M2018: $6.05M2019: -$8.33M2020: -$16.60M2021: $7.37M2022: $12.48M2023: $11.31M2024: $7.49M2025: $129.38M$129.38M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$129.38M+1626.9%2024$7.49M-33.8%2023$11.31M-9.3%2022$12.48M+69.4%2021$7.37M+144.4%2020-$16.60M-99.3%2019-$8.33M-237.7%2018$6.05M-29.0%2017$8.52M-24.8%2016$11.33M+128.1%2015$4.97M-72.0%2014$17.72M+110.5%2013$8.42M+20.7%2012$6.97M+320.1%2011$1.66M-78.9%2010$7.85M+256.6%2009-$5.02M-96.2%2008-$2.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share